ARTLVSXXII• 3 Months (Normalized)
ARTL vs XXII (Artelo Biosciences Inc. vs 22nd Century Group Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-54.55%
Artelo Biosciences Inc.
Normalized Baseline0.00%
XXII Performance $1.33
-66.83%
22nd Century Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ARTL LEADS
+12.28 pts
ARTL outperforming by 12.28 percentage points
ARTLXXII
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL XXII
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | ARTL Price | ARTL Gain (%) | XXII Price | XXII Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -54.55% | $1.33 | -66.83% | +12.28% |
| Sep 24, 2026 | $5.17 | -48.25% | $1.51 | -62.34% | +14.09% |
| Sep 23, 2026 | $7.31 | -26.83% | $2.34 | -41.65% | +14.82% |
| Sep 22, 2026 | $4.15 | -58.46% | $1.81 | -54.86% | -3.60% |
| Sep 21, 2026 | $4.10 | -58.96% | $1.77 | -55.86% | -3.10% |
| Sep 18, 2026 | $3.94 | -60.56% | $1.79 | -55.36% | -5.20% |
| Sep 17, 2026 | $3.97 | -60.26% | $1.77 | -55.86% | -4.40% |
| Sep 16, 2026 | $3.75 | -62.46% | $1.72 | -57.11% | -5.35% |
| Sep 15, 2026 | $5.34 | -46.55% | $1.80 | -55.24% | +8.69% |
| Sep 14, 2026 | $4.87 | -51.25% | $1.85 | -53.87% | +2.62% |
| Sep 11, 2026 | $5.43 | -45.65% | $1.99 | -50.37% | +4.72% |
| Sep 10, 2026 | $5.63 | -43.64% | $2.05 | -49.00% | +5.36% |
| Sep 09, 2026 | $5.98 | -40.14% | $2.13 | -46.88% | +6.74% |
| Sep 08, 2026 | $6.19 | -38.04% | $2.29 | -42.89% | +4.85% |
| Sep 04, 2026 | $6.04 | -39.54% | $2.45 | -38.90% | -0.64% |
Page 1 of 4